keyword
https://read.qxmd.com/read/38696542/predominance-of-oxa-48-carbapenemase-producing%C3%A2-klebsiella-pneumoniae%C3%A2-strains-in-tertiary-hospital-in-sarajevo-bosnia-and-herzegovina
#1
JOURNAL ARTICLE
Amela Dedeić Ljubović, Đana Granov, Edina Zahirović, Azra Čamdžić, Adis Muhić, Irma Salimović Bešić
Klebsiella pneumoniae, a member of the Enterobacteriaceae family, demonstrates an increasing trend of resistance to carbapenems and is a common cause of both hospital- and community-acquired infections. The current study provides insights into the genetic characterization of carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates circulating during 2022 in a Sarajevo tertiary hospital. Among the 87 CRKP strains analyzed, real-time polymerase chain reaction (rtPCR) results showed that 85 (97.7%) tested positive for the carbapenem resistance gene...
May 2, 2024: Biomol Biomed
https://read.qxmd.com/read/38676579/-comparison-of-three-different-methods-in-investigating-the-molecular-epidemiology-of-carbapenem-resistant-acinetobacter-baumannii-clinical-isolates
#2
COMPARATIVE STUDY
Gülşen Uluçam Atay, Gülçin Bayramoğlu, İlknur Tosun, Ülkü Ünsal
The aim of the study was to evaluate the relationship between carbapenem-resistant Acinetobacter baumannii isolates carrying oxacillinase-type carbapenemase genes with "international high-risk clones" (IC I, II, and III) by different molecular epidemiological methods and to statistically compare the concordance and discrimination power of the methods. Carbapenem-resistant and moderately susceptible A.baumannii isolates from non-repeating blood cultures of 72 patients were included in the study. The presence of "blaOXA-23 , blaOXA-24 , blaOXA-51 ve blaOXA-58 " genes within OXA-type carbapenemases was detected by polymerase chain reaction (PCR) method and confirmed by DNA sequence analysis...
April 2024: Mikrobiyoloji Bülteni
https://read.qxmd.com/read/38674749/in-silico-molecular-analysis-of-carbapenemase-negative-carbapenem-resistant-pseudomonas-aeruginosa-strains-in-greece
#3
JOURNAL ARTICLE
Katerina Tsilipounidaki, Christos-Georgios Gkountinoudis, Zoi Florou, George C Fthenakis, Efthymia Petinaki
To date, three carbapenem resistance mechanisms have been identified: carbapenemase released from the pathogen, changes in the expression of the outer membrane OprD porin, and overexpression of the efflux pump MexAB-OprM. Twelve carbapenemase-negative carbapenem-resistant Pseudomonas aeruginosa strains, isolated from patients hospitalized at the University Hospital of Larissa, Central Greece, during 2023, which belonged to various sequence types (STs), were selected and were studied focusing on the characterization of their β -lactamases, on changes to OprD and its regulator MexT proteins, and on alterations to the MexAB-OprM regulator proteins encoded by the mexR , nalC , and nalD genes...
April 16, 2024: Microorganisms
https://read.qxmd.com/read/38674079/molecular-epidemiology-of-carbapenem-resistant-klebsiella-aerogenes-in-japan
#4
JOURNAL ARTICLE
Kentarou Takei, Miho Ogawa, Ryuji Sakata, Hajime Kanamori
Information regarding Klebsiella aerogenes haboring carbapenemase in Japan is limited. A comprehensive nationwide survey was conducted from September 2014 to December 2022, and 67 non-duplicate strains of carbapenem-resistant K. aerogenes were isolated from 57 healthcare facilities in Japan. Through genetic testing and whole-genome sequencing, six strains were found to possess carbapenemases, including imipenemase (IMP)-1, IMP-6, New Delhi metallo-β-lactamase (NDM)-1, and NDM-5. The strain harboring bla NDM-5 was the novel strain ST709, which belongs to the clonal complex of the predominant ST4 in China...
April 19, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38577805/outbreak-of-carbapenemase-producing-citrobacter-farmeri-in-an-intensive-care-haematology-department-linked-to-a-persistent-wastewater-reservoir-in-one-hospital-room-france-2019-to-2022
#5
JOURNAL ARTICLE
Marie Regad, Julie Lizon, Corentine Alauzet, Gabrielle Roth-Guepin, Caroline Bonmati, Simona Pagliuca, Alain Lozniewski, Arnaud Florentin
In 2019-2022, a prolonged outbreak of oxacillinase (OXA)-48-producing Citrobacter farmeri due to a persistent environmental contamination, occurred in our haematology intensive care unit. In April 2019, we isolated OXA-48-producing C. farmeri from rectal samples of two patients in weekly screenings. The cases had stayed in the same hospital room but 4 months apart. We screened five patients who had stayed in this room between the two cases and identified a third case. Over the following 3 years, five other cases were detected, the last case in September 2022...
April 2024: Euro Surveillance
https://read.qxmd.com/read/38552877/in-vitro-activity-pharmacodynamic-profile-and-dose-optimization-of-biapenem-against-ndm-and-oxa-48-like-carbapenemase-producing-klebsiella-pneumoniae-a-multicenter-study-in-thailand
#6
JOURNAL ARTICLE
Worapong Nasomsong, Chirakhana Siangtrong, Parnrada Nulsopapon, Supanun Pungcharoenkijkul, Patcharapa Boonmee, Wichai Santimaleeworagun
BACKGROUND: Biapenem (BIPM) exhibited a less efficient substrate for various Metallo-β-lactamase (MBL) than other carbapenems. OBJECTIVE: We aimed to evaluate in vitro susceptibility data of BIPM, and optimal dose based on Monte Carlo simulation to extend treatment options. METHODS: We collected 192 carbapenem-resistant Klebsiella pneumoniae (CRKP) clinical isolates from unique patients among multicenters in Thailand, from June 2019-March 2023...
March 27, 2024: Journal of Global Antimicrobial Resistance
https://read.qxmd.com/read/38550619/identification-of%C3%A2-antibiotic-resistance-genes-in%C3%A2-escherichia-coli-from-subclinical-mastitis-milk-in%C3%A2-dairy-cows-and-goats-east-java-province
#7
JOURNAL ARTICLE
Desy Cahya Widianingrum, Denada Grace Silaban, Wahyu Indra Duwi Fanata, Himmatul Khasanah
Antibiotics are still used to treat mastitis in dairy cows in Indonesia. This study aimed to analyse antibiotic resistance genes in  Escherichia coli ( E. coli ) from subclinical mastitis milk in East Java Province, Indonesia. The samples consisted of subclinical mastitis milk from cows and goats. A total of 592-quarter cow's milk and 71 goat's milk samples from both halves of the udder were collected from 67 farms in Lumajang, Banyuwangi, Malang, Sidoarjo, Jember, Pasuruan, Probolinggo, and Mojokerto...
February 2024: Veterinární Medicína
https://read.qxmd.com/read/38505565/analysis-of-carbapenem-resistant-acinetobacter-baumannii-carbapenemase-gene-distribution-and-biofilm-formation
#8
JOURNAL ARTICLE
Lin Wang, Qi-Wei Chen, Yan-Chun Qin, Xue-Li Yi, Hong Zeng
OBJECTIVE: In recent years, Acinetobacter baumannii has been appearing in hospitals with high drug resistance and strong vitality, which brings many difficulties to clinical treatment. In this study, 255 strains of A. baumannii were isolated from Youjiang Medical University for Nationalities Affiliated Hospital clinical samples and found to be highly resistant to carbapenems. The drug resistance, biofilm-forming ability, and carbapenase gene distribution of 145 carbapenem-resistant A...
2024: International Journal of Molecular Epidemiology and Genetics
https://read.qxmd.com/read/38483164/-in-vitro-activity-of-cefiderocol-against-european-pseudomonas-aeruginosa-and-acinetobacter-spp-including-isolates-resistant-to-meropenem-and-recent-%C3%AE-lactam-%C3%AE-lactamase-inhibitor-combinations
#9
JOURNAL ARTICLE
Anne Santerre Henriksen, Katy Jeannot, Antonio Oliver, John D Perry, Mathias W Pletz, Stefania Stefani, Ian Morrissey, Christopher Longshaw
UNLABELLED: Carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. represent major threats and have few approved therapeutic options. Non-‍fermenting Gram-negative isolates were collected from hospitalized inpatients from 49 sites in 6 European countries between 01 January 2020 and 31 December 2020 and underwent susceptibility testing against cefiderocol and β-lactam/β-lactamase inhibitor combinations. Meropenem-resistant (MIC >8 mg/L), cefiderocol-susceptible isolates were analyzed by PCR, and cefiderocol-resistant isolates were analyzed by whole-genome sequencing to identify resistance mechanisms...
March 14, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38329363/-in-vitro-activity-of-ceftazidime-avibactam-and-comparators-against-oxa-48-like-enterobacterales-collected-between-2016-and-2020
#10
JOURNAL ARTICLE
Gregory Stone, Mark Wise, Eric Utt
Oxacillinases (OXA)-48-like β-lactamases are one of the most common resistance determinants among carbapenem-resistant Enterobacterales reported globally. Moreover, there is no standard treatment available against organisms producing OXA-48-like enzymes, and they are sometimes difficult to detect, making treatment challenging. The objective of this study was to evaluate the distribution and antimicrobial susceptibility of bla OXA-48-like Enterobacterales isolates against ceftazidime-avibactam (CAZ-AVI) and a panel of comparators collected worldwide from 2016 to 2020 as a part of the Antimicrobial Testing Leadership and Surveillance program...
February 8, 2024: Microbiology Spectrum
https://read.qxmd.com/read/38289044/meropenem-ant3310-a-unique-%C3%AE-lactam-%C3%AE-lactamase-inhibitor-combination-with-expanded-antibacterial-spectrum-against-gram-negative-pathogens-including-carbapenem-resistant-acinetobacter-baumannii
#11
JOURNAL ARTICLE
Magdalena Zalacain, Pauline Achard, Agustina Llanos, Ian Morrissey, Stephen Hawser, Kirsty Holden, Eleanor Toomey, David Davies, Simon Leiris, Carole Sable, Adeline Ledoux, Justine Bousquet, Jérôme Castandet, Clarisse Lozano, Martin Everett, Marc Lemonnier
ANT3310 is a novel broad-spectrum diazabicyclooctane serine β-lactamase inhibitor being developed in combination with meropenem (MEM) for the treatment of serious infections in hospitalized patients where carbapenem-resistant Gram-negative pathogens are expected. In this study, we evaluated the in vitro antibacterial activity of MEM in the presence of ANT3310 at 8 µg/mL against global clinical isolates that included Acinetobacter baumannii ( n = 905), carbapenem-resistant Enterobacterales (CRE), carrying either oxacillinase (OXA) ( n = 252) or Klebsiella pneumoniae carbapenemase (KPC) ( n = 180) carbapenemases, and Pseudomonas aeruginosa ( n = 502)...
January 30, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38161376/an-ion-pair-induced-intermediate-complex-captured-in-class-d-carbapenemase-reveals-chloride-ion-as-a-janus-effector-modulating-activity
#12
JOURNAL ARTICLE
Qi Zhou, Pablo Catalán, Helen Bell, Patrick Baumann, Rebekah Cooke, Rhodri Evans, Jianhua Yang, Zhen Zhang, Davide Zappalà, Ye Zhang, George Michael Blackburn, Yuan He, Yi Jin
Antibiotic-resistant Enterobacterales that produce oxacillinase (OXA)-48-like Class D β-lactamases are often linked to increased clinical mortality. Though the catalytic mechanism of OXA-48 is known, the molecular origin of its biphasic kinetics has been elusive. We here identify selective chloride binding rather than decarbamylation of the carbamylated lysine as the source of biphasic kinetics, utilizing isothermal titration calorimetry (ITC) to monitor the complete reaction course with the OXA-48 variant having a chemically stable N -acetyl lysine...
December 27, 2023: ACS Central Science
https://read.qxmd.com/read/38092671/-in-vivo-dose-response-and-efficacy-of-the-%C3%AE-lactamase-inhibitor-durlobactam-in-combination-with-sulbactam-against-the-acinetobacter-baumannii-calcoaceticus-complex
#13
JOURNAL ARTICLE
John O'Donnell, Angela Tanudra, April Chen, Joseph Newman, Sarah M McLeod, Rubén Tommasi
Multi-drug resistant (MDR) Acinetobacter baumannii is emerging as a pathogen of increasing prevalence and concern. Infections associated with this Gram-negative pathogen are often associated with increased morbidity and mortality and few therapeutic options. The β-lactamase inhibitor sulbactam used commonly in combination with ampicillin demonstrates intrinsic antibacterial activity against A. baumannii acting as an inhibitor of PBP1 and PBP3, which participate in cell wall biosynthesis. The production of β-lactamases, particularly class D oxacillinases, however, has limited the utility of sulbactam resorting to increased doses and the need for alternate therapies...
January 10, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/37964192/acinetobacter-spp-bloodstream-infection-in-hematological-patients-a-10-year-single-center-study
#14
JOURNAL ARTICLE
Jia Li, Xiaomeng Feng, Jieru Wang, Qingsong Lin, Yizhou Zheng, Fengkui Zhang, Yingchang Mi, Xiaofan Zhu, Erlie Jiang, Zhijian Xiao, Jianxiang Wang, Sizhou Feng
PURPOSE: This study investigated the clinical and antimicrobial characteristics of Acinetobacter spp. bloodstream infection (BSI) in hematological patients. Risk factors for 30-day mortality and carbapenem-resistant Acinetobacter spp. (CRA) BSI acquisition were also identified. METHODS: We reviewed forty hematological patients with Acinetobacter spp. BSI in a large Chinese blood disease hospital between 2013 and 2022. The remaining CRA isolates were subjected to whole-genome sequencing...
November 14, 2023: BMC Infectious Diseases
https://read.qxmd.com/read/37941878/early-detection-of-a-possible-multidrug-resistant-acinetobacter-baumannii-outbreak-in-the-local-hospital-setting-by-using-random-amplified-polymorphism-dna-polymerase-chain-reaction-rapd-pcr-oxacillinase-gene-profiles-and-antibiograms
#15
JOURNAL ARTICLE
Ni Nengah Dwi Fatmawati, Gede Ngurah Rsi Suwardana, Ida Ayu Gde Wahyudevi Dharmika, Ni Made Adi Tarini, I Nengah Sujaya, I Wayan Suranadi
BACKGROUND AND OBJECTIVES: Detecting the source of a potential outbreak of multidrug resistant (MDR) Acinetobacter baumannii is necessary to be investigated. This study aimed to detect the possibility of A. baumannii outbreak in a hospital setting using a combination of random amplified polymorphism DNA-polymerase chain reaction (RAPD-PCR), antibiograms, and the presence of oxacillinase genes. MATERIALS AND METHODS: The antibiogram of 31 clinical isolates and six environmental isolates of A...
October 2023: Iranian Journal of Microbiology
https://read.qxmd.com/read/37928684/phylogenomics-of-acinetobacter-species-and-analysis-of-antimicrobial-resistance-genes
#16
JOURNAL ARTICLE
Antonella Migliaccio, James Bray, Michele Intoccia, Maria Stabile, Giovanni Scala, Keith A Jolley, Sylvain Brisse, Raffaele Zarrilli
INTRODUCTION: Non- baumannii Acinetobacter species are increasingly isolated in the clinical setting and the environment. The aim of the present study was to analyze a genome database of 837 Acinetobacter spp. isolates, which included 798 non- baumannii Acinetobacter genomes, in order to define the concordance of classification and discriminatory power of 7-gene MLST, 53-gene MLST, and single-nucleotide polymorphism (SNPs) phylogenies. METHODS: Phylogenies were performed on Pasteur Multilocus Sequence Typing (MLST) or ribosomal Multilocus Sequence Typing (rMLST) concatenated alleles, or SNPs extracted from core genome alignment...
2023: Frontiers in Microbiology
https://read.qxmd.com/read/37892720/identification-of-the-bla-oxa-23-gene-in-the-first-mucoid-xdr-acinetobacter-baumannii-isolated-from-a-patient-with-cystic-fibrosis
#17
Martina Rossitto, Gianluca Vrenna, Vanessa Tuccio Guarna Assanti, Nour Essa, Maria Luisa De Santis, Annarita Granaglia, Vanessa Fini, Valentino Costabile, Manuela Onori, Luca Cristiani, Alessandra Boni, Renato Cutrera, Carlo Federico Perno, Paola Bernaschi
Acinetobacter baumannii is one of the pathogens most involved in health care-associated infections in recent decades. Known for its ability to accumulate several antimicrobial resistance mechanisms, it possesses the oxacillinase bla oxa-23 , a carbapenemase now endemic in Italy. Acinetobacter species are not frequently observed in patients with cystic fibrosis, and multidrug-resistant A. baumannii is a rare event in these patients. Non-mucoid A. baumannii carrying the bla oxa-23 gene has been sporadically detected...
October 18, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37887182/in-vitro-activity-of-new-%C3%AE-lactamase-inhibitor-combinations-against-bla-ndm-bla-kpc-and-esbl-producing-enterobacteriales-uropathogens
#18
JOURNAL ARTICLE
Lubna Razaq, Fakhur Uddin, Shahzad Ali, Shah Muhammad Abbasi, Muhammad Sohail, Nabila E Yousif, Hala M Abo-Dief, Zeinhom M El-Bahy
Antibiotic resistance in uropathogens has increased substantially and severely affected treatment of urinary tract infections (UTIs). Lately, some new formulations, including meropenem/vaborbactam (MEV), ceftazidime/avibactam (CZA), and ceftolozane/tazobactam (C/T) have been introduced to treat infections caused by drug-resistant pathogens. This study was designed to screen Enterobacteriales isolates from UTI patients and to assess their antimicrobial resistance pattern, particularly against the mentioned (new) antibiotics...
September 25, 2023: Antibiotics
https://read.qxmd.com/read/37875361/molecular-epidemiology-of-clinical-isolation-of-carbapenem-resistant-enterobacterales-and-application-of-carbapenemase-inhibitor-enhancement-test
#19
JOURNAL ARTICLE
Hongling Li, Yiming Zhong, Qun Yan, Wen'en Liu, Xianghui Liang
OBJECTIVES: The prevalence of carbapenem-resistant Enterobacterales (CRE) presents a significant challenge in clinical anti-infective treatment. This study aims to investigate drug resistance and the molecular epidemiological characteristics of CRE in our area. Additionally, we seek to evaluate practicality of utilizing carbapenemase inhibitor enhancement test in clinical laboratory. METHODS: Non-repeated CREs isolated from clinical specimens at Xiangya Hospital, Central South University, were collected...
August 28, 2023: Zhong Nan da Xue Xue Bao. Yi Xue Ban, Journal of Central South University. Medical Sciences
https://read.qxmd.com/read/37764160/-acinetobacter-baumannii-ic2-and-ic5-isolates-with-co-existing-bla-oxa-143-like-and-bla-oxa-72-and-exhibiting-strong-biofilm-formation-in-a-mexican-hospital
#20
JOURNAL ARTICLE
Julia Moreno-Manjón, Santiago Castillo-Ramírez, Keith A Jolley, Martin C J Maiden, Catalina Gayosso-Vázquez, José Luis Fernández-Vázquez, Valeria Mateo-Estrada, Silvia Giono-Cerezo, María Dolores Alcántar-Curiel
Acinetobacter baumannii is an opportunistic pathogen responsible for healthcare-associated infections (HAIs) and outbreaks. Antimicrobial resistance mechanisms and virulence factors allow it to survive and spread in the hospital environment. However, the molecular mechanisms of these traits and their association with international clones are frequently unknown in low- and middle-income countries. Here, we analyze the phenotype and genotype of seventy-six HAIs and outbreak-causing A. baumannii isolates from a Mexican hospital over ten years, with special attention to the carbapenem resistome and biofilm formation...
September 14, 2023: Microorganisms
keyword
keyword
57665
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.